Search results
Clinical inertia: failure of healthcare providers to initiate or intensify therapy when indicated, due to: overestimation of care provided. use of “soft” reasons to avoid intensification of therapy. lack of education, training, and practice organization aimed at achieving therapeutic goals.
Check out our comprehensive chart to understand how your meds work, and keep the list handy for times when your health care provider suggests changes to your treatment plan. More > KEY: *Cost is based on the lowest-priced drug in its class. Low-cost drugs are less than $1 per day. Medium-cost drugs are between $1 and $2 per day.
- 177KB
- 4
This updated guideline provides recommendations for the care and management of people with or at risk for diabetes mellitus at every stage, including prevention, diagnosis, and treatment.
Jan 4, 2024 · The initial treatment of type 2 diabetes in older patients is similar to that in younger patients and includes counseling on nutrition, physical activity, optimizing metabolic control, and preventing complications.
Key points to emphasize. New information -- Updated October 5, 2018 at EASD meeting in Berlin. Update informed by evidence generated in the past 2 years. Greater focus on lifestyle interventions, with increased emphasis on weight loss and obesity management, including metabolic surgery.
Dec 4, 2020 · For patients prone to glycemic variability, especially patients with type 1 diabetes or type 2 diabetes with severe insulin deficiency, glycemic control is best evaluated by the combination of results from SMBG or CGM and A1C.
Some medications help prevent diabetes complications, including renin-angiotensin-aldosterone system blockers (angiotensin-converting enzyme [ACE] inhibitors or angiotensin II receptor blockers [ARBs]), statins, and aspirin.
